TTY Biopharm Company Limited announced that Kao, Jung-Liang will be replaced with Chiang, Yung-Min, Senior Manager of Finance Department of Synmosa Biopharma Corporation, as internal audit officer, effective November 7, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
76.2 TWD | -0.39% |
|
-0.39% | -5.22% |
May. 30 | TTY Biopharm Company Limited Announces Change of Members of Audit Committee | CI |
May. 30 | TTY Biopharm Company Limited Announces Change of Members of Sustainable Development Committee | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-5.22% | 585M | |
+63.05% | 854B | |
+39.42% | 636B | |
-4.78% | 361B | |
+17.52% | 324B | |
+8.43% | 301B | |
+14.19% | 247B | |
+5.81% | 230B | |
+16.77% | 228B | |
+14.63% | 177B |
- Stock Market
- Equities
- 4105 Stock
- News TTY Biopharm Company Limited
- TTY Biopharm Company Limited Announces Internal Audit Officer Changes, Effective November 7, 2022